Avid Bioservices, Inc. (NASDAQ: CDMO) Q2 2022 earnings call dated Dec. 07, 2021 Corporate Participants: Tim Brons -- Investor Relations, Vida Strategic Partners Nicholas
Avid Bioservices, Inc. (CDMO) Q2 2022 Earnings Call Transcript
Categories
Biotechnology
IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO
After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed for a
Biogen (BIIB) stock research summary | Q3 2021
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these
Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2021 Earnings Call Transcript
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) Q4 2021 earnings call, dated Nov. 22, 2021. Corporate Participants: Vince Anzalone -- Vice President of Investor Relations Christopher
Cara Therapeutics, Inc. (CARA) Q3 2021 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ: CARA) Q3 2021 earnings call dated Nov. 08, 2021 Corporate Participants: Will Gramig -- Senior Analyst Derek Chalmers -- Chief Executive Officer,
Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business
Evelo Biosciences Inc (EVLO) Q3 2021 Earnings Call Transcript
Evelo Biosciences Inc (NASDAQ: EVLO) Q3 2021 earnings call dated Oct. 28, 2021 Corporate Participants: Kendra Sweeney -- Head of Investor Relations
Avalo Therapeutics CEO Mike Cola on product pipeline and market potential
Credit:DavidBGray on iStock What’s the significance of the name change and why now? Mike: The why now is because we have really
Avid Bioservices Inc (CDMO) Q1 2021 Earnings Call Transcript
Avid Bioservices Inc (NASDAQ: CDMO) Q1 2021 earnings call dated Sep. 08, 2021. Corporate Participants: Tim Brons -- Avid's Investor Relations Group Nicholas
IPO Alert: COVID-19 test maker Cue Health is all set to go public
Just eight months into the year, IPO activity has already reached all-time highs, with tech firms and biotechnology startups leading the rally.
Moderna (MRNA): Here are a few points to note while considering this stock
Shares of Moderna Inc. (NASDAQ: MRNA) were up 6% on Monday. The stock has gained 291% since the beginning of the year
IPO Alert: What investors need to know about Procept BioRobotics’ upcoming market debut
The medical device market has been in the spotlight ever since coronavirus tightened its grip across the world last year as the
IPO News: Should you invest in RenovoRx’s upcoming IPO?
As healthcare startups continue to flock to the stock market, extending the hectic activity seen in the first half, the IPO market
Cara Therapeutics, Inc. CARA) Q2 2021 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ: CARA) Q2 2021 earnings call dated Aug. 09, 2021 Corporate Participants: Cole Herlitz-Ferguson -- Investor Relations Derek Chalmers -- Chief Executive Officer,
IPO News: What to look for when Eliem Therapeutics goes public?
Extending the IPO frenzy that sweeped the market in the early part of the year, emerging biotechnology companies continue to flock to
Moderna, Inc. (MRNA) Q2 2021 Earnings Call Transcript
Moderna, Inc. (NASDAQ: MRNA) Q2 2021 earnings call dated Aug. 05, 2021 Corporate Participants: Lavina Talukdar -- Senior Vice President & Head of Investor
Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Call Transcript
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q2 2021 earnings call dated Aug. 03, 2021 Corporate Participants: Andrea N. Flynn -- Vice President and Head of
IPO News: What awaits Adagio Therapeutics after stock market debut?
The favorable regulatory environment and convenient options like direct listing continue to lure emerging businesses to the stock market. The latest statistics
IPO News: Here’s everything you need to know about Healthcare Royalty’s upcoming IPO
In the first half of 2021, a record number of private companies entered stock markets in the US, marking a multifold increase
ImmunoGen Inc. (IMGN) Q2 2021 Earnings Call Transcript
ImmunoGen Inc. (NASDAQ: IMGN) Q2 2021 earnings call dated Jul. 30, 2021 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor
Gilead Sciences Inc (GILD) Q2 2021 Earnings Call Transcript
Gilead Sciences Inc (NASDAQ: GILD) Q2 2021 earnings call dated Jul. 29, 2021. Corporate Participants: Jacquie Ross -- Investor Relations Daniel O'Day --